Capital 10X interviews Cresco Labs
They discuss the newly legalized Illinois market, including the supply challenges facing the different players in the space. As Bachtell details, Cresco Labs is well situated with a large cultivation footprint and distribution network.
He also elaborates on the Origin House acquisition now that it has closed, detailing the value they bring to Cresco and the opportunities for synergistic cost reductions.
Finally, he discusses the canceling of the VidaCann acquisition and why they are still evaluating opportunities in the Florida market.
The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Capital 10X hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.